SCHEMBL25098529

SCHEMBL25098529

COCCOC(=O)c1ccc(-c2cncc(C(F)(F)F)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTPS1 P17812 6/20 0.45
CHEK1 O14757 1/20 0.42
PTGS2 P35354 2/20 0.41
ABCB11 O95342 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2B P18089 1/20 0.40
OPRD1 P41143 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN10A Q9Y5Y9 2/20 0.40
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
HDAC4 P56524 3/20 0.38
HDAC6 Q9UBN7 2/20 0.38
TSHR P16473 1/20 0.38
SCN2A Q99250 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24369756 0.85 CTPS1 (0.49) CTPS1CHEK1SCN10ACA1CA2
SCHEMBL21392044 0.80 CTPS1 (0.48) CTPS1CHEK1SCN10ASCN2ACA1
SCHEMBL21391994 0.76 CHEK1 (0.56) CTPS1CHEK1MEN1RAB9AKMT2A
SCHEMBL14930468 0.75 KDM4E (0.53) PTGS2ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL14930476 0.75 KDM4E (0.53) PTGS2ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL30416354 0.75 CHEK1 (0.50) CTPS1CHEK1
SCHEMBL24369906 0.73 MAPK1 (0.47) CTPS1SCN10ATSHRSCN2AMAPT
SCHEMBL9969969 0.72 TSHR (0.64) ABCB11CYP3A4ADRA2BOPRD1SCN5A
SCHEMBL24088641 0.72 CTPS1 (0.47) CTPS1SCN10ATSHRSCN2AMAPT
SCHEMBL31676659 0.72 CTPS1 (0.47) CTPS1SCN10ATSHRSCN2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230077316-A1 CTPS1 INHIBITORS AND USES THEREOF NIMBUS DISCOVERY, INC. 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230077316-A1 CTPS1 INHIBITORS AND USES THEREOF CTPS1, CTPS2, ECHS1 CTPS1 1/4885CHEK1 658/4885PTGS2 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.